Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014
Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018
Screening and monitoring of tuberculosis in patients on biologics treatment Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of infection with mycobacterium tuberculosis Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Identification of novel tuberculosis diagnostic biomarkers in plasma and saliva Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Monitoring and evaluation of LTBI management Source: International Congress 2015 – Latent tuberculosis infection Year: 2015
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015
Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Source: Eur Respir J 2008; 32: 1607-1615 Year: 2008
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection Source: Eur Respir J 2013; 42: 547-550 Year: 2013